ILMN250117P132000
- 0.66
- 0.000.00%
Illumina Newsroom
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Baird Maintains Illumina(ILMN.US) With Hold Rating, Raises Target Price to $144
Illumina, Inc.'s (NASDAQ:ILMN) Price Is Out Of Tune With Revenues
Life Sciences Stocks Fall on NIH Funding Concerns
Cathie Wood's Ark Invest Buys Into Defense And Energy Stocks Amid Trump's Inaugural Policies
Illumina Partners NVIDIA for Genomic Advancements, ILMN Stock Climbs
Grail 2024 Revenue Guidance Range Above Consensus
BofA Securities Maintains Illumina(ILMN.US) With Sell Rating, Maintains Target Price $120
Bernstein Maintains Illumina(ILMN.US) With Hold Rating
Sector Update: Health Care Stocks Fall Tuesday Afternoon
Express News | Illumina Shares Reverse Premarket Losses, Now up 2.5%
Illumina, Nvidia Collaborate to Decode Biology and Propel Precision Health
Illumina Announces Preliminary Financials For Q4 2024 With $1.10B Revenue, 2024 Revenue At $4.33B, GAAP EPS $5.65-$5.67; Non-GAAP EPS $4.12-$4.14; Sees 2025 Revenue Outlook Of $4.28B-$4.4B, Non-GAAP Margin 23%, EPS Growth 10%
Nvidia Eyes $1 Billion In Healthcare AI Revenue: Is This The Next Growth Frontier?
Express News | Illumina Shares Fall 3.6% Premarket After Prelim Q4 Results
Express News | Illumina Inc Q4 Shr View $0.91, Rev View $1.07 Bln -- LSEG IBES Data
Illumina Sees 4Q Rev $1.1B >ILMN
Illumina Sees 4Q EPS 77c-EPS 79c >ILMN
Express News | Illumina: For FY 2025, Expect Constant Currency Revenue Growth in Low Single Digits (Reported Revenue in Range of About $4.28 Bln to $4.4 Bln)
Express News | Illumina Inc: Preliminary Non-Gaap Diluted EPS of Approximately $0.91 - $0.93 for Q4 2024